Akebia Therapeutics Inc
For the period ended Dec 31, 2024. Filed Mar 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We currently lease approximately 65,167 square feet of office, storage and laboratory space in Cambridge, Massachusetts, which is our corporate headquarters. Excluding renewal options, the lease for our Cambridge, Massachusetts office, storage and lab space expires on September 11, 2026. Due to our primarily hybrid workforce, we are marketing up to 59,216 square feet of furnished office space for sublease. We believe our existing facilities are adequate to meet our operational needs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.